737 related articles for article (PubMed ID: 7855790)
1. Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats.
Yamazaki M; Asakura H; Aoshima K; Saito M; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Ikeda T; Matsuda T
Thromb Haemost; 1994 Sep; 72(3):392-6. PubMed ID: 7855790
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of DX-9065a, an orally active, novel synthesized and selective inhibitor of factor Xa, against thromboplastin-induced experimental disseminated intravascular coagulation in rats.
Yamazaki M; Asakura H; Aoshima K; Saito M; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Ikeda T; Matsuda T
Semin Thromb Hemost; 1996; 22(3):255-9. PubMed ID: 8836010
[TBL] [Abstract][Full Text] [Related]
3. DX-9065a, an orally active, specific inhibitor of factor Xa, inhibits thrombosis without affecting bleeding time in rats.
Hara T; Yokoyama A; Tanabe K; Ishihara H; Iwamoto M
Thromb Haemost; 1995 Aug; 74(2):635-9. PubMed ID: 8584999
[TBL] [Abstract][Full Text] [Related]
4. Effects of ticlopidine and aspirin on endotoxin-induced disseminated intravascular coagulation in rats.
Yoshikawa T; Murakami M; Furukawa Y; Takemura S; Kondo M
Thromb Haemost; 1983 Jun; 49(3):190-2. PubMed ID: 6879507
[TBL] [Abstract][Full Text] [Related]
5. Effect of vitamin E on endotoxin-induced disseminated intravascular coagulation in rats.
Yoshikawa T; Furukawa Y; Murakami M; Watanabe K; Kondo M
Thromb Haemost; 1982 Oct; 48(2):235-7. PubMed ID: 7179203
[TBL] [Abstract][Full Text] [Related]
6. DX 9065A a novel, synthetic, selective and orally active inhibitor of factor Xa: in vitro and in vivo studies.
Herbert JM; Bernat A; Dol F; Hérault JP; Crépon B; Lormeau JC
J Pharmacol Exp Ther; 1996 Mar; 276(3):1030-8. PubMed ID: 8786532
[TBL] [Abstract][Full Text] [Related]
7. Effects of superoxide dismutase and catalase on disseminated intravascular coagulation in rats.
Yoshikawa T; Murakami M; Yoshida N; Seto O; Kondo M
Thromb Haemost; 1983 Dec; 50(4):869-72. PubMed ID: 6665768
[TBL] [Abstract][Full Text] [Related]
8. DX-9065a, an orally active factor Xa inhibitor, does not facilitate haemorrhage induced by tail transection or gastric ulcer at the effective doses in rat thrombosis model.
Tanabe K; Morishima Y; Shibutani T; Terada Y; Hara T; Shinohara Y; Aoyagi K; Kunitada S; Kondo T
Thromb Haemost; 1999 May; 81(5):828-34. PubMed ID: 10365760
[TBL] [Abstract][Full Text] [Related]
9. The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits.
Bregengård C; Nordfang O; Wildgoose P; Svendsen O; Hedner U; Diness V
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):699-706. PubMed ID: 8292719
[TBL] [Abstract][Full Text] [Related]
10. 6,7-Dihydroxy-3-phenylcoumarin inhibits thromboplastin induced disseminated intravascular coagulation.
Tunali T; Yarat A; Bulut M; Emekli N
Br J Haematol; 2004 Jul; 126(2):226-30. PubMed ID: 15238144
[TBL] [Abstract][Full Text] [Related]
11. DX-9065a, a new synthetic, potent anticoagulant and selective inhibitor for factor Xa.
Hara T; Yokoyama A; Ishihara H; Yokoyama Y; Nagahara T; Iwamoto M
Thromb Haemost; 1994 Mar; 71(3):314-9. PubMed ID: 8029795
[TBL] [Abstract][Full Text] [Related]
12. Effect of dipyridamole on experimental disseminated intravascular coagulation in rats.
Yoshikawa T; Murakami M; Furukawa Y; Takemura S; Kondo M
Thromb Res; 1983 Mar; 29(6):619-25. PubMed ID: 6857600
[TBL] [Abstract][Full Text] [Related]
13. Effect of urinary protein C inhibitor on lipopolysaccharide-induced disseminated intravascular coagulation in rats.
Fujita M; Izutani W; Komurasaki Y
Thromb Haemost; 2000 Jul; 84(1):54-8. PubMed ID: 10928470
[TBL] [Abstract][Full Text] [Related]
14. A specific inhibitor of factor Xa, DX-9065a, exerts effective protection against experimental tumor induced disseminated intravascular coagulation in rats.
Tanabe K; Terada Y; Shibutani T; Kunitada S; Kondo T
Thromb Res; 1999 Oct; 96(2):135-43. PubMed ID: 10574591
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of ONO-3307, a new synthetic protease inhibitor against experimental disseminated intravascular coagulation in rats.
Yoshikawa T; Takeda S; Naito Y; Kondo M
Thromb Res; 1990 Oct; 60(1):1-7. PubMed ID: 2278034
[TBL] [Abstract][Full Text] [Related]
16. Effects of FUT-175, a new synthetic protease inhibitor on endotoxin-induced disseminated intravascular coagulation in rats.
Yoshikawa T; Murakami M; Furukawa Y; Kato H; Takemura S; Kondo M
Haemostasis; 1983; 13(6):374-8. PubMed ID: 6667905
[TBL] [Abstract][Full Text] [Related]
17. The effects of higenamine on LPS-induced experimental disseminated intravascular coagulation (DIC) in rats.
Yun-Choi HS; Pyo MK; Chang KC; Lee DH
Planta Med; 2002 Apr; 68(4):326-9. PubMed ID: 11988856
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of disseminated intravascular coagulation (DIC) progresses at a different rate in tissue factor-induced and lipopolysaccharide-induced DIC models in rats.
Asakura H; Suga Y; Yoshida T; Ontachi Y; Mizutani T; Kato M; Ito T; Morishita E; Yamazaki M; Miyamoto K; Nakao S
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):221-8. PubMed ID: 12695743
[TBL] [Abstract][Full Text] [Related]
19. Treatment of disseminated intravascular coagulation (DIC) with all-trans retinoic acid in an endotoxin-induced rat model.
Aoshima K; Asakura H; Yamazaki M; Saito M; Kumabashiri I; Morishita E; Ontachi Y; Mizutani T; Ichino T; Matsuda T
Semin Thromb Hemost; 1998; 24(3):227-31. PubMed ID: 9701452
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic effect of recombinant human soluble thrombomodulin on endotoxin-induced disseminated intravascular coagulation in rats.
Gonda Y; Hirata S; Saitoh K; Aoki Y; Mohri M; Gomi K; Sugihara T; Kiyota T; Yamamoto S; Ishida T
Thromb Res; 1993 Aug; 71(4):325-35. PubMed ID: 8236161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
